Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*.
Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*.
复制标题
DOI:
10.1097/ccm.0b013e318250a887
复制
发表时间:
2012-07
影响因子:
8.8
通讯作者:
Rice TW
中科院分区:
文献类型:
--
作者:
Hooper MH;Weavind L;Wheeler AP;Martin JB;Gowda SS;Semler MW;Hayes RM;Albert DW;Deane NB;Nian H;Mathe JL;Nadas A;Sztipanovits J;Miller A;Bernard GR;Rice TW
To determine whether automated identification with physician notification of the systemic inflammatory response syndrome in medical intensive care unit (MICU) patients expedites early administration of new antibiotics or improvement of other patient outcomes in patients with sepsis. A prospective, randomized, controlled, single-center study. MICU of an academic, tertiary-care medical center. 442 consecutive patients admitted over a 4 month period who met modified SIRS criteria in a MICU. Patients were randomized to monitoring by an electronic “Listening Application” to detect modified (SIRS) criteria vs. usual care. The Listening Application notified physicians in real-time when modified SIRS criteria were detected, but did not provide management recommendations. The median time to new antibiotics was similar between the intervention and usual care groups whether comparing among all patients (6.0h vs 6.1h, p=0.95), patients with sepsis (5.3h vs. 5.1h; p=0.90), patients on antibiotics at enrollment (5.2h vs. 7.0h, p= 0.27), or patients not on antibiotics at enrollment (5.2h vs. 5.1h, p= 0.85). The amount of fluid administered following detection of modified SIRS criteria was similar between groups whether comparing all patients or only patients hypotensive at enrollment. Other clinical outcomes including ICU length of stay, hospital length of stay, and mortality were not shown to be different between patients in the intervention and control groups. Real-time alerts of modified SIRS criteria to physicians in one tertiary care MICU were feasible and safe but did not influence measured therapeutic interventions for sepsis or significantly alter clinical outcomes.